annb0t
Top 20
Recce Pharmaceuticals
Highlights:
10 subjects in cohort seven were intravenously dosed with RECCE® 327 at 6,000mg Independent Safety Committee reviewing cohort seven data and anticipate a recommendation to proceed to cohort eight Overall study objectives achieved with a focus on establishing a dose ceiling Phase 2 protocol under development based upon efficacious doses determined in previous animal studies
SYDNEY, Australia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX...
>>> Read more: Recce Pharmaceuticals Announces Positive Safety Data from Seventh Cohort of Phase 1 Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
Highlights:
10 subjects in cohort seven were intravenously dosed with RECCE® 327 at 6,000mg Independent Safety Committee reviewing cohort seven data and anticipate a recommendation to proceed to cohort eight Overall study objectives achieved with a focus on establishing a dose ceiling Phase 2 protocol under development based upon efficacious doses determined in previous animal studies
SYDNEY, Australia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX...
>>> Read more: Recce Pharmaceuticals Announces Positive Safety Data from Seventh Cohort of Phase 1 Clinical Trial Evaluating Healthy Subjects Intravenously Dosed with RECCE® 327
